U.S. Markets open in 4 hrs 11 mins
  • S&P Futures

    4,312.50
    -5.25 (-0.12%)
     
  • Dow Futures

    33,957.00
    -86.00 (-0.25%)
     
  • Nasdaq Futures

    14,030.00
    +43.25 (+0.31%)
     
  • Russell 2000 Futures

    1,912.10
    -16.20 (-0.84%)
     
  • Crude Oil

    86.94
    +0.33 (+0.38%)
     
  • Gold

    1,789.90
    -3.20 (-0.18%)
     
  • Silver

    22.53
    -0.14 (-0.62%)
     
  • EUR/USD

    1.1140
    -0.0007 (-0.0668%)
     
  • 10-Yr Bond

    1.8070
    0.0000 (0.00%)
     
  • Vix

    30.64
    -1.32 (-4.13%)
     
  • GBP/USD

    1.3377
    -0.0004 (-0.0334%)
     
  • USD/JPY

    115.6130
    +0.3110 (+0.2697%)
     
  • BTC-USD

    36,516.95
    -100.08 (-0.27%)
     
  • CMC Crypto 200

    827.54
    +8.04 (+0.98%)
     
  • FTSE 100

    7,474.71
    -79.60 (-1.05%)
     
  • Nikkei 225

    26,717.34
    +547.04 (+2.09%)
     

Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • XENE

BURNABY, British Columbia, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that Ian Mortimer, Xenon’s President and Chief Executive Officer, along with Sherry Aulin, Xenon’s Chief Financial Officer, will participate virtually in the following investor conferences:

  • Guggenheim 3rd Annual Neuro/Immunology Conference on Monday, November 15, 2021 (one-on-one meetings only)

  • Stifel 2021 Virtual Healthcare Conference on Wednesday, November 17, 2021, with fireside chat presentation at 1:20 pm ET

  • Jefferies London Healthcare Conference on Thursday, November 18, 2021, with on-demand streaming of fireside chat presentation beginning at 8:00 am GMT / 3:00 am ET

The above listed dates and times are subject to change. Details on company presentations and webcasts can be found on the “Investors” section of Xenon's website at investor.xenon-pharma.com. When available, webcasts will be posted for replay following the event.

About Xenon Pharmaceuticals Inc.

We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com